MiNK Therapeutics, Inc. INKT
10.79 USD -0.25 (-2.26%)
At closeNov 3, 2026, 4:00 PM EST
11.00 +0.21 +1.95%
After hours · Nov 3, 4:00 PM ET
10.70 Day range 11.27
8.48 52-week range 16.93
- YTD
- -3.23%
- 1 year
- -19.78%
Financial health
Altman Z-Score
-26.18 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -3.8×
FY 2019 5y median -3.1× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B -3.3×
FY 2019 5y median -2.0× FY 2025
P/FCF -8.0×
FY 2019 5y median -4.6× FY 2025
EV/EBITDA -3.2×
FY 2019 5y median -2.5× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -12.4%
FY 2019 5y median -21.8% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE 87.8%
FY 2019 5y median 87.8% FY 2025
ROIC -195.5%
FY 2019 5y median -78.3% FY 2025
ROA -87.7%
FY 2019 5y median -130.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -17.2%
FY 2019 FY 2025
EPS (diluted) -4.6%
FY 2019 FY 2025
Free Cash Flow 38.0%
FY 2019 FY 2025
Financial Health
Current Ratio 1.1×
FY 2019 5y median 1.1× FY 2025
Quick Ratio 1.1×
FY 2019 5y median 1.1× FY 2025
Debt / Equity -0.4×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2019 5y median 0.7× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31